Vimarsana
Biggest News Aggregation in the World

Page 44 - Zymeworks Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zymeworks Inc Today - Breaking & Trending Today

Fintel Short Squeeze Leaderboard Identifies Short Squeeze Opportunities for Traders - Vimarsana News

Fintel Short Squeeze Leaderboard Identifies Short Squeeze Opportunities for Traders

Fintel’s short interest data identifies candidates for the week of May 1, 2022

Exclusive-All Blue Capital in $773 million bid for Zymeworks -sources - Vimarsana News

Exclusive-All Blue Capital in $773 million bid for Zymeworks -sources

By Anirban Sen (Reuters) -Investment firm All Blue Capital has approached Zymeworks Inc, a developer of antibody therapies for cancer, with a $773 mil...

Source: whbl.com
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points - Vimarsana News

Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday. Following the market opening Friday, the D...

Vancouver-based Zymeworks Receives US $773 Million (Non-Binding) Acquisition Offer From All Blue Falcons FZE, Stock Pops 36% - Vimarsana News

Vancouver-based Zymeworks Receives US $773 Million (Non-Binding) Acquisition Offer From All Blue Falcons FZE, Stock Pops 36%

Vancouver-based Zymeworks Receives US $773 Million (Non-Binding) Acquisition Offer From All Blue Falcons FZE, Stock Pops 36%. Vancouver, BC, April 29, 2022--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, confirmed that it has received an unsolicited, non-binding acquisition proposal from All Blue Falcons FZE ("ABF") and its affiliates to purchase the Company for $10.50 per share in cash.

Zymeworks Inc. (NYSE:ZYME) Expected to Announce Quarterly Sales of $3.76 Million - Vimarsana News

Zymeworks Inc. (NYSE:ZYME) Expected to Announce Quarterly Sales of $3.76 Million

Equities analysts expect that Zymeworks Inc. (NYSE:ZYME – Get Rating) will post sales of $3.76 million for the current quarter, according to Zacks. Four analysts have issued estimates for Zymeworks’ earnings, with the highest sales estimate coming in at $6.00 million and the lowest estimate coming in at $1.75 million. Zymeworks posted sales of $640,000.00 […]